Related Experiment Video
Updated: May 6, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate
Timothy Caulfield1, Jim Evans, Amy McGuire
1Health Law Institute, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us about potential benefits and harms, particularly in the context of health care policy. The scale and pace of adoption of this powerful new technology should be driven by clinical need, clinical evidence, and a commitment to put patients at the centre of health care policy.
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Sanger Sequencing
Genomics
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...
Genome Size and the Evolution of New Genes
Genome Size and the Evolution of New Genes

